Stock Market Reviews

TARS (Tarsus Pharmaceuticals, Inc.) News

Get the latest news, insights, and market updates on TARS (Tarsus Pharmaceuticals, Inc.). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• This Eye Treatment Stock Sees Sales Spike 152% As Biotech Leaders Shine
  Biotech stocks are performing well in the stock market in August and a few in the IBD 50 have formed bases with clear buy points.
  Aug 15, 2025 - $TARS
• Lyme Disease Is Spiking. This Biotech Nears A Treatment And A Buy Point.
  This biotech is nearing a buy point of a cup base. The company has a treatment for Lyme disease in its pipeline.
  Aug 14, 2025 - $TARS
• Analyst Estimates: Here's What Brokers Think Of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) After Its Second-Quarter Report
  NasdaqGS:TARS 1 Year Share Price vs Fair Value Explore Tarsus Pharmaceuticals's Fair Values from the Community and...
  Aug 9, 2025 - $TARS
• Tarsus Reports Second Quarter 2025 Financial Results and Recent Business Achievements
  Record quarterly net product sales of $102.7 million achieved within two years of our XDEMVY® launch, an increase of 152% year over year Direct-To-Consumer campaign has activated new patients, expanded base and depth of prescribers and led to a meaningful increase in prescriptions Pipeline advancements and global efforts remain on track Management to host conference call today, August 6, 2025, at 1:30 p.m. PT / 4:30 p.m. ET IRVINE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals
  Aug 6, 2025 - $TARS
• Tarsus Pharmaceuticals, Inc. (TARS) Reports Q2 Loss, Tops Revenue Estimates
  Tarsus Pharmaceuticals (TARS) delivered earnings and revenue surprises of -45.45% and +9.94%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
  Aug 6, 2025 - $TARS
• Tarsus to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025
  IRVINE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that it will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET on Wednesday, August 6, 2025, to report its second quarter 2025 financial results and provide a corporate update. Participants may access the webcast here. A recorded version of the call will be available on the website shortly after the completion of the webcast and will be archived there for approximately 90 days. About T
  Jul 30, 2025 - $TARS
• Tarsus Pharmaceuticals, Inc.'s (NASDAQ:TARS) Path To Profitability
  With the business potentially at an important milestone, we thought we'd take a closer look at Tarsus Pharmaceuticals...
  Jul 24, 2025 - $TARS
• Tarsus Pharmaceuticals (TARS) Loses -15.59% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
  The heavy selling pressure might have exhausted for Tarsus Pharmaceuticals (TARS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
  May 14, 2025 - $TARS
• Tarsus Pharmaceuticals, Inc. (TARS): Among the Best Breakout Stocks to Buy According to Analysts
  We recently published a list of 11 Best Breakout Stocks to Buy According to Analysts. In this article, we are going to take a look at where Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) stands against other best breakout stocks to buy according to analysts. Stock markets have been on edge in response to the US President’s aggressive […]
  May 5, 2025 - $TARS
• Analysts Just Made A Substantial Upgrade To Their Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Forecasts
  Celebrations may be in order for Tarsus Pharmaceuticals, Inc. ( NASDAQ:TARS ) shareholders, with the analysts...
  May 4, 2025 - $TARS